Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| KLA Corporation(KLAC) | 19,883 | 178,471 | +158,588 | $29.28M | $53.85M | 25.18% | +$24.57M |
| Bristol-Myers Squibb Company(BMY) | 306,268 | 297,243 | -9,025 | $18.58M | $17.13M | 8.01% | -$1.45M |
| Lam Research Corporation(LRCX) | 36,000 | 35,000 | -1,000 | $7.69M | $15.17M | 7.09% | +$7.47M |
| Solid Biosciences Inc | 625,980 | 666,196 | +40,216 | $4.51M | $6.66M | 3.11% | +$2.15M |
| Intellia Therapeutics, Inc.(NTLA) | 445,400 | 385,400 | -60,000 | $5.71M | $6.52M | 3.05% | +$810.9K |
| Biodesix, Inc.(BDSX) | 286,804 | 286,804 | 0 | $4.16M | $6.47M | 3.02% | +$2.31M |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 178,110 | -31,890 | $6.84M | $5.83M | 2.73% | -$1.01M |
| Ovintiv Inc.(OVV) | 107,500 | 107,500 | 0 | $6.38M | $5.66M | 2.65% | -$721.3K |
| Nektar Therapeutics(NKTR) | 31,000 | 81,000 | +50,000 | $2.23M | $5.65M | 2.64% | +$3.42M |
| Corcept Therapeutics Incorporated(CORT) | 47,200 | 57,200 | +10,000 | $1.90M | $4.97M | 2.33% | +$3.07M |
| Neurocrine Biosciences, Inc.(NBIX) | 27,190 | 27,190 | 0 | $3.58M | $4.58M | 2.14% | +$1.00M |
| Prothena Corp PlcSHS SHS | 449,019 | 449,019 | 0 | $4.36M | $4.40M | 2.06% | +$31.4K |
| Acadia Pharmaceuticals Inc | 171,000 | 171,000 | 0 | $3.81M | $4.33M | 2.02% | +$519.8K |
| Protagonist Therapeutics Inc | 35,000 | 35,018 | +18 | $3.69M | $4.29M | 2.01% | +$603.5K |
| Compass Therapeutics, Inc.(CMPX) | 1,465,867 | 1,675,000 | +209,133 | $7.75M | $3.67M | 1.72% | -$4.09M |
| Relmada Therapeutics, Inc.(RLMD) | 409,387 | 408,100 | -1,287 | $2.85M | $2.82M | 1.32% | -$25.3K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.77M | $2.62M | 1.23% | +$851.8K |
| Halozyme Therapeutics, Inc.(HALO) | 10,100 | 33,251 | +23,151 | $652.8K | $2.60M | 1.22% | +$1.95M |
| Celldex Therapeutics, Inc.(CLDX) | 70,095 | 69,900 | -195 | $2.22M | $2.60M | 1.22% | +$377.6K |
| Cytokinetics, Incorporated(CYTK) | 30,000 | 30,000 | 0 | $1.98M | $2.56M | 1.20% | +$578.4K |
| Olema Pharmaceuticals, Inc.(OLMA) | 219,000 | 199,000 | -20,000 | $3.27M | $2.49M | 1.16% | -$775.8K |
| Vera Therapeutics, Inc.CL A(VERA) | 44,000 | 57,758 | +13,758 | $1.77M | $2.48M | 1.16% | +$708.3K |
| United Therapeutics Corporation(UTHR) | 4,500 | 4,506 | +6 | $2.67M | $2.44M | 1.14% | -$226.9K |
| Zenas BioPharma, Inc.(ZBIO) | 70,000 | 93,601 | +23,601 | $1.37M | $2.38M | 1.11% | +$1.01M |
| uniQure N.V.SHS(QURE) | 100,697 | 50,697 | -50,000 | $1.65M | $2.34M | 1.09% | +$688.7K |
| Pacific Biosciences of California, Inc.(PACB) | 1,500,000 | 1,350,000 | -150,000 | $1.98M | $2.27M | 1.06% | +$288.0K |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 17,000 | +17,000 | $0 | $2.27M | 1.06% | +$2.27M |
| Vir Biotechnology, Inc.(VIR) | 0 | 220,000 | +220,000 | $0 | $2.24M | 1.05% | +$2.24M |
| Biogen Inc.(BIIB) | 5,000 | 9,000 | +4,000 | $916.6K | $1.94M | 0.91% | +$1.03M |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $2.20M | $1.84M | 0.86% | -$362.5K |
| BioAge Labs, Inc.(BIOA) | 0 | 69,000 | +69,000 | $0 | $1.69M | 0.79% | +$1.69M |
| Travere Therapeutics, Inc.(TVTX) | 29,200 | 29,000 | -200 | $867.5K | $1.65M | 0.77% | +$780.0K |
| Quidelortho Corp | 82,548 | 89,377 | +6,829 | $1.36M | $1.57M | 0.73% | +$209.2K |
| Axsome Therapeutics, Inc.(AXSM) | 6,000 | 6,000 | 0 | $1.01M | $1.47M | 0.69% | +$454.5K |
| Foghorn Therapeutics Inc.(FHTX) | 281,730 | 281,937 | +207 | $1.35M | $1.38M | 0.64% | +$29.2K |
| Bicycle Therapeutics PlcADS | 463,599 | 313,616 | -149,983 | $2.15M | $1.33M | 0.62% | -$821.4K |
| Structure Therapeutics IncADR | 100,000 | 24,000 | -76,000 | $4.82M | $1.29M | 0.60% | -$3.53M |
| Xenon Pharmaceuticals Inc.(XENE) | 21,000 | 21,032 | +32 | $1.22M | $1.27M | 0.59% | +$48.3K |
| Novo Nordisk A/SADR(NVO) | 0 | 24,000 | +24,000 | $0 | $1.15M | 0.54% | +$1.15M |
| Freeport-McMoRan Inc.CL B(FCX) | 18,040 | 18,035 | -5 | $1.06M | $1.13M | 0.53% | +$73.8K |
| Immunome, Inc.(IMNM) | 50,000 | 50,000 | 0 | $1.09M | $1.06M | 0.50% | -$34.0K |
| Pharvaris N V COM | 29,847 | 29,847 | 0 | $843.2K | $1.03M | 0.48% | +$188.9K |
| Harrow, Inc.(HROW) | 24,000 | 24,000 | 0 | $846.2K | $1.02M | 0.48% | +$173.0K |
| Adagene IncADS | 0 | 240,000 | +240,000 | $0 | $1.01M | 0.47% | +$1.01M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 20,000 | +20,000 | $0 | $940.8K | 0.44% | +$940.8K |
| Silence Therapeutics plcADS(SLN) | 0 | 71,218 | +71,218 | $0 | $782.0K | 0.37% | +$782.0K |
| BridgeBio Pharma, Inc.(BBIO) | 8,688 | 8,741 | +53 | $645.2K | $651.0K | 0.30% | +$5.9K |
| 4d Molecular Therapeutics Inc | 0 | 48,505 | +48,505 | $0 | $645.1K | 0.30% | +$645.1K |
| UroGen Pharma Ltd.(URGN) | 0 | 16,487 | +16,487 | $0 | $606.7K | 0.28% | +$606.7K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 195,000 | 55,000 | -140,000 | $2.17M | $596.8K | 0.28% | -$1.57M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 0 | 120,000 | +120,000 | $0 | $524.4K | 0.25% | +$524.4K |
| Savara Inc.(SVRA) | 0 | 80,000 | +80,000 | $0 | $492.8K | 0.23% | +$492.8K |
| Candel Therapeutics, Inc.(CADL) | 60,000 | 47,756 | -12,244 | $294.0K | $491.9K | 0.23% | +$197.9K |
| Altimmune, Inc.(ALT) | 0 | 152,681 | +152,681 | $0 | $464.1K | 0.22% | +$464.1K |
| COMPASS Pathways plcADS(CMPS) | 375,000 | 30,000 | -345,000 | $2.07M | $424.5K | 0.20% | -$1.65M |
| Karyopharm Therapeutics Inc.(KPTI) | 83,952 | 42,952 | -41,000 | $467.6K | $419.6K | 0.20% | -$48.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $284.2K | $364.2K | 0.17% | +$80.0K |
| Trinity Capital Inc.(TRIN) | 20,000 | 20,000 | 0 | $294.2K | $357.8K | 0.17% | +$63.6K |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 14,352 | +14,352 | $0 | $345.6K | 0.16% | +$345.6K |
| Castle Biosciences, Inc.(CSTL) | 12,900 | 12,984 | +84 | $316.7K | $309.7K | 0.14% | -$7.0K |
| Invivyd, Inc.(IVVD) | 0 | 342,275 | +342,275 | $0 | $298.6K | 0.14% | +$298.6K |
| Grace Therapeutics, Inc.(GRCE) | 50,000 | 120,000 | +70,000 | $231.5K | $272.4K | 0.13% | +$40.9K |
| Kayne Anderson BDC, Inc.(KBDC) | 20,000 | 20,000 | 0 | $274.4K | $270.6K | 0.13% | -$3.8K |
| Voyager Therapeutics, Inc.(VYGR) | 74,918 | 75,147 | +229 | $289.2K | $263.0K | 0.12% | -$26.2K |
| Pulmonx Corporation(LUNG) | 250,221 | 200,543 | -49,678 | $322.8K | $260.7K | 0.12% | -$62.1K |
| Intellia Therapeutics, Inc.45826J105(NTLA) | 445,400 | 500 | -444,900 | $5.71M | $260.0K | 0.12% | -$5.45M |
| Ocular Therapeutix, Inc.(OCUL) | 320,000 | 20,655 | -299,345 | $2.71M | $202.8K | 0.09% | -$2.51M |
| Kyntra Bio, Inc.(KYNB) | 22,566 | 22,566 | 0 | $153.0K | $170.4K | 0.08% | +$17.4K |
| Elutia Inc.(ELUT) | 165,094 | 165,094 | 0 | $173.3K | $161.7K | 0.08% | -$11.6K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 20,000 | 20,000 | 0 | $132.0K | $96.8K | 0.05% | -$35.2K |
| Lipocine Inc.(LPCN) | 111,786 | 16,712 | -95,074 | $893.2K | $42.8K | 0.02% | -$850.4K |
| DocGo Inc.(DCGO) | 39,573 | 39,062 | -511 | $24.9K | $20.2K | 0.01% | -$4.7K |
| Gossamer Bio, Inc.(GOSS) | 18,176 | 18,176 | 0 | $6.0K | $3.0K | 0.00% | -$3.0K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 0 | -14,000 | $563.2K | $0 | — | -$563.2K |
| Apogee Therapeutics Inc | 9,000 | 0 | -9,000 | $757.5K | $0 | — | -$757.5K |
| Arcus Biosciences, Inc.(RCUS) | 25,889 | 0 | -25,889 | $559.2K | $0 | — | -$559.2K |
| Engene Holdings Inc COM | 250,000 | 0 | -250,000 | $1.70M | $0 | — | -$1.70M |
| IDEAYA Biosciences, Inc.(IDYA) | 16,860 | 0 | -16,860 | $561.8K | $0 | — | -$561.8K |
| Kalvista Pharmaceuticals Inc | 57,000 | 0 | -57,000 | $1.15M | $0 | — | -$1.15M |
| NovoCure Limited(NVCR) | 202,330 | 0 | -202,330 | $2.21M | $0 | — | -$2.21M |
| Outset Medical, Inc.(OM) | 98,882 | 0 | -98,882 | $379.7K | $0 | — | -$379.7K |
| Phreesia, Inc.(PHR) | 14,300 | 0 | -14,300 | $119.8K | $0 | — | -$119.8K |
| REGENXBIO Inc.(RGNX) | 66,270 | 0 | -66,270 | $555.3K | $0 | — | -$555.3K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 127,025 | 0 | -127,025 | $454.8K | $0 | — | -$454.8K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 62,000 | 0 | -62,000 | $1.30M | $0 | — | -$1.30M |
| Verastem, Inc.(VSTM) | 150,000 | 0 | -150,000 | $795.0K | $0 | — | -$795.0K |
| Viridian Therapeutics, Inc.(VRDN) | 20,100 | 0 | -20,100 | $393.2K | $0 | — | -$393.2K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 17,503 | 0 | -17,503 | $41.0K | $0 | — | -$41.0K |